A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma
A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma
Recruiting · NCT06071871 · Registry updated 2024-12-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma | large B-cell lymphoma | Recruiting | Phase 2 | 2024-12-24 | NCT06071871 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hoffmann-La Roche | 280 |
| University College, London | 222 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Churchill Hospital | Oxford | United Kingdom | 17 |
| Kings College Hospital NHS Foundation Trust | London | United Kingdom | 5 |
| Nottingham University Hospitals NHS Trust | Nottingham | United Kingdom | 25 |
| The Christie NHS Foundation Trust | Manchester | United Kingdom | 40 |
| University College London Hospitals NHS Foundation Trust | London | United Kingdom | 16 |